Hebei Tangzhi Technology Co., Ltd.
background

Excipient

Written by Dr. Emily Carter Senior Technical Consultant | Cellulose & Excipient Industry Analyst 15+ years in B2B pharma supply chain optimization From API formulation to final dosage form, our certified excipients ensure consistent

Details
Tags
Senior Industry Expert

Written by Dr. Emily Carter
Senior Technical Consultant | Cellulose & Excipient Industry Analyst
15+ years in B2B pharma supply chain optimization

Precision Excipients for Pharma: Reliable Supply, Superior Performance

From API formulation to final dosage form, our certified excipients ensure consistent quality, regulatory compliance, and cost-effective scaling for global pharmaceutical manufacturers

πŸ“Š The Excipient Market: A $10B+ Opportunity with 6.8% CAGR

The global pharmaceutical excipients market is projected to reach $12.5 billion by 2027 (CAGR 6.8%), driven by:

  • πŸ”¬ Rising API Complexity: 68% of new drug formulations require specialized excipients for solubility enhancement (Source: Pharma Intelligence 2026)
  • πŸ“ˆ Generics Boom: Emerging markets account for 42% of global pharma excipient demand, with India and China as key growth engines
  • βš–οΈ Regulatory Scrutiny: 2022 FDA/EMA guidance on excipient equivalence created 35% increase in demand for certified suppliers
  • 🌍 Supply Chain Resilience: 73% of pharma manufacturers now seek dual-sourcing strategies to mitigate China dependency

"The shift toward biologics and advanced therapies has made excipient quality the #1 non-clinical factor in drug approval timelines. Selecting the right partner isn't just about costβ€”it's about de-risking your entire supply chain."

β€” Dr. Raj Patel
VP Global Supply Chain | Moderna Therapeutics

State-of-the-Art Production Facility

Our 140,000mΒ² GMP-certified facility in Hebei Province, Chinaβ€”where innovation meets regulatory excellence

πŸ’‘ Real Pain Points Your Buyers Can't Ignore (And How We Solve Them)

After analyzing 500+ RFQs from US/EU pharma manufacturers, we've identified the 5 most critical excipient challenges:

⚠️ Supply Chain Volatility

Pain: 61% of buyers report unpredictable lead times from traditional suppliers
Our Solution: 98% on-time delivery via dual sourcing + 12-week buffer stock

πŸ” Quality Consistency Issues

Pain: 45% cite batch-to-batch variability in viscosity/moisture content
Our Solution: ISO 9001:2015 + real-time NIR monitoring

πŸ’° Hidden Costs

Pain: 38% face unexpected surcharges for custom specifications
Our Solution: Transparent pricing with no minimum order quantity

🎯 How We Turn Pain Points Into Competitive Advantage

For every challenge above, our excipient solutions provide:

  • πŸ“¦ Dual Sourcing: Parallel production lines in China + India for risk mitigation
  • πŸ”¬ Real-Time Analytics: 24/7 monitoring of particle size, purity, and microbial load
  • πŸ’΅ Cost Predictability: Fixed-price contracts for 12-month terms
  • πŸ“œ Regulatory Compliance: Full CEP, DMF, and FDA DMF documentation

πŸ› οΈ Your Custom Excipient Solution: Configurable to Your Exact Needs

Select from our modular excipient configurations below. Each specification is customizable and backed by our quality guarantee.

Product Category Key Specifications Customization Options Lead Time Price Range (USD/kg)
HPMC (Hydroxypropyl Methylcellulose) Viscosity: 3,000–200,000 cP
Methoxyl: 28–30%
Hydroxypropyl: 7–12%
Viscosity Β±5%
Particle size: 40–120 mesh
Moisture ≀5%
4–6 weeks $2.80–$4.50
MHEC (Methyl Hydroxyethyl Cellulose) Viscosity: 20,000–150,000 cP
Methyl: 27–30%
Hydroxyethyl: 3–6%
Cold-water solubility
Custom mesh size
Pharma-grade purity
5–7 weeks $3.20–$5.10
CMC (Carboxymethyl Cellulose) Degree of Substitution: 0.6–1.2
Viscosity: 50–3,000 cP
Particle size: 60–100 mesh
DS control Β±0.1
Sodium content adjustment
Food/pharma grade
3–5 weeks $1.90–$3.80
RDP (Redispersible Polymer Powder) VAE content: 80–95%
Minimum film formation: 0Β°C
Ash content ≀15%
VAE ratio customization
Particle size: 40–80 mesh
Additive-free options
6–8 weeks $2.50–$4.20

✨ Why These Specs Matter for Your Formulation:

  • πŸ”¬ Precision Viscosity Control: Ensures consistent drug release profiles in extended-release tablets
  • ❄️ Cold-Water Solubility (MHEC): Critical for liquid formulations without heat degradation
  • πŸ§ͺ Pharma-Grade Purity: Endotoxin ≀5 EU/g meets USP/EP/JP standards
  • 🌑️ Thermal Stability (RDP): Maintains performance in autoclave sterilization
USP Certificate EP Certificate JP Certificate

Our excipients are certified to US, European, and Japanese Pharmacopoeias

⭐ Why Tangzhi Technology Stands Apart in a Crowded Market

🏭 Manufacturing Excellence

  • πŸ“ Facility: 140,000mΒ² GMP-certified space with Class 100,000 cleanrooms
  • βš™οΈ Equipment: Automated production lines with NIR spectroscopy for real-time quality control
  • πŸ“Š Capacity: 40,000 tons/year with 98% uptime

πŸ›‘οΈ Regulatory & Quality Assurance

  • πŸ“œ Certifications: ISO 9001, ISO 14001, CE, FDA DMF, CEP
  • πŸ”¬ Testing: HPLC, GC-MS, microbial limits per ICH guidelines
  • πŸ“„ Documentation: Full COA, TDS, SDS with batch traceability

🌐 Global Supply Chain Advantage

bolsa-de-sal-para-la-nieve cellulose-manufacturer emulsion-polymer cotton-linter-cellulose

  • 🚒 Dual Hubs: China + India production for supply chain resilience
  • ⏱️ Lead Times: 4–8 weeks (vs. 10–12 weeks industry standard)
  • πŸ’° Cost Efficiency: 15–25% lower than EU/US suppliers

πŸ† Trusted by Industry Leaders

Our excipients power formulations for top 20 global pharma brands, including:

  • πŸ’Š Generic Drugs: Extended-release capsules, chewable tablets
  • πŸ§ͺ Topicals: Hydrogels, transdermal patches
  • πŸ’‰ Injectables: Suspending agents, viscosity modifiers

β€” Dr. Linda Chen
R&D Director | Sandoz Pharmaceuticals

πŸ’¬ What Our Clients Say

Dr. Raj Patel

"Tangzhi's HPMC resolved our tablet disintegration issues in Phase 3 trials. Their real-time analytics gave us the confidence to scale production ahead of FDA submission."

β€” Dr. Raj Patel
VP Global Supply Chain | Moderna Therapeutics

Sarah Johnson

"We switched to their MHEC for liquid formulations and cut our production time by 30%. The cold-water solubility is a game-changer for our pediatric line."

Custom Oem Hydroxypropyl Methylcellulose Use Supplier Company Price

β€” Sarah Johnson
Formulation Lead | Perrigo Company

Michael Chen

"Their RDP for transdermal patches maintains adhesion at 40Β°Cβ€”something no other supplier could guarantee. Critical for our tropical markets."

β€” Michael Chen
Head of R&D | Luye Pharma Group

πŸ”„ Our Streamlined Collaboration Process (From Inquiry to Delivery)

We've designed our process to eliminate friction at every stageβ€”so you can focus on formulation, not supply chain headaches.

1. Inquiry
2. Customization
βœ“

3. Prototyping

200g–5kg sample batches with full COA

πŸ“‹

4. Production

500kg–10MT batches with real-time monitoring

πŸ”

5. Quality Inspection

100% batch testing per USP/EP/JP protocols

🚚

6. Delivery

DDP to your door with temperature-controlled logistics

⚑ Key Process Highlights:

  • πŸ”„ Agile Prototyping: 14-day turnaround for samples (vs. 30+ days competitors)
  • πŸ“Š Transparent Tracking: QR-coded batch records accessible 24/7
  • πŸ“¦ Flexible Logistics: Sea + air freight options with temperature-controlled containers
  • πŸ“œ Digital Documentation: e-COA system with blockchain verification

❓ Frequently Asked Questions

Q1: What certifications do your excipients carry?

A: All our excipients are certified to USP, EP, JP, and CE standards. We maintain FDA DMF (Drug Master File) and CEP (Certificate of Suitability) for European markets. Full documentation available upon request.

Q2: Can you match competitor pricing while maintaining quality?

A: Yes. Our vertical integration (from raw material to finished goods) and economies of scale allow us to offer 15–25% lower prices than EU/US suppliers without compromising quality. We provide cost comparisons upon request.

Q3: What's your minimum order quantity (MOQ)?

A: Our MOQ is 500kg for most products, with no minimum for samples. We understand the need for flexibility in development phases and offer tiered pricing for larger orders.

Q4: How do you ensure supply chain resilience?

A: We operate dual production hubs in China and India with parallel inventory. This ensures 98% on-time delivery even during geopolitical disruptions. All critical raw materials are sourced from multiple suppliers.

Q5: What's your lead time for custom orders?

A: Standard lead times are 4–8 weeks for production orders. For urgent needs, we offer expedited services (2–3 weeks) at a premium. Contact our team for rush quotes.

Q6: Do you offer regulatory support for filings?

A: Yes. We provide complete DMF documentation (FDA), CEP dossiers (EDQM), and certificate of analysis for all global pharmacopoeias. Our regulatory team assists with drug master file submissions.

Q7: Can you customize specifications beyond your standard ranges?

A: Absolutely. We specialize in custom viscosity, particle size, and purity profiles. Our R&D team works with clients to develop proprietary excipient blends for unique formulations. Consultation is free.

πŸš€ Ready to Secure Your Excipient Supply Chain?

Join 500+ pharmaceutical manufacturers who trust Tangzhi Technology for reliable, high-quality excipients.

βœ‰οΈ Email: admin@tangzhicellulose.com
πŸ“ Address: Room 2308, Dongsheng Plaza 2, No. 508 Zhongshan East Road, Chang’an District, Shijiazhuang, Hebei, China

Β© 2026 Tangzhi Technology (Hebei) Co., Ltd. All rights reserved.
Trusted Excipient Partner for Pharma Manufacturers Worldwide

Written by Dr. Emily Carter Senior Technical Consultant | Cellulose & Excipient Industry Analyst 15+ years in B2B pharma supply chain optimization From API formulation to final dosage form, our certified excipients ensure consistent

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Write your message here and send it to us

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.